Multi-target synergistic oil control composition and cosmetics applying same

Abstract

The invention relates to a multi-target synergistic oil control composition and cosmetics using the same, and the composition comprises a hamamelis virginiana extract, a stephania tetrandra extract and dipotassium glycyrrhizinate, and also comprises cosmetically acceptable auxiliary materials, the auxiliary materials comprise one or more of a solvent, a humectant, a skin conditioner, an emulsifier, a thickener, a softening and moistening agent, a skin feeling regulator, a pH regulator and a preservative. By the adoption of the technical scheme, the problem that oil is removed through hamamelis virginiana is solved, but the drying risk is possibly caused; the stephania tetrandra extract reduces the grease yield from the inflammation source; the dipotassium glycyrrhizinate ensures that the whole oil control process is carried out in an environment with a healthy skin barrier and a stable nerve reaction, side effects are prevented, so that the durability and safety of oil control are remarkably improved, and the composition is particularly suitable for oily skin with inflammation and sensitivity due to the synergism.

Description

TECHNICAL FIELD

[0001] The present application relates to the field of cosmetics, in particular to a multi-target synergistic oil control composition and its application in cosmetics. BACKGROUND

[0002] Excessive secretion of skin oil is the root cause of a series of problems such as oiliness, large pores, acne, etc. The current market oil control products mainly rely on the following mechanisms:

[0003] Physical adsorption: using porous materials such as talc and silica to adsorb oil, which is a temporary solution and may block pores.

[0004] Strong astringency: using high-concentration alcohol or acidic ingredients (such as salicylic acid) to instantly shrink pores, but long-term use can damage the skin barrier, leading to dryness, sensitivity, and even trigger compensatory oil secretion.

[0005] Single pathway inhibition: using vitamin B3 (niacinamide), which is effective but slow-acting, and has limited effect on oil secretion caused by inflammation, nerve stress, etc.

[0006] The main defects of the prior art are: single means, unable to cope with the complex physiological regulation network of oil secretion (nerve, inflammation, barrier, etc.); focusing on immediate effect while ignoring long-term skin health, which can easily lead to barrier damage and sensitivity problems.

[0007] Therefore, there is an urgent need in the art for a comprehensive oil control solution that can simultaneously act on multiple key links of oil secretion, including normal secretion of sebaceous glands and excessive secretion of oil caused by inflammation, and can quickly take effect and maintain stability, while being gentle and not damaging the skin barrier. SUMMARY

[0008] The purpose of the present application: in order to overcome the defects of the prior art, the present application provides a multi-target synergistic oil control composition and its application in cosmetics, which constructs a multi-target synergistic network by precise compounding of Hamamelis virginiana extract, Stephania tetrandra extract and dipotassium glycyrrhizinate, realizes the comprehensive oil control effect of instant and long-acting combination, and synchronous oil control and soothing.

[0009] The technical scheme of the present application provides a multi-target synergistic oil control composition, which comprises Hamamelis virginiana extract, Stephania tetrandra extract and dipotassium glycyrrhizinate.

[0010] By adopting the above technical scheme, the components such as tannic acid in Hamamelis virginiana extract have significant astringent properties, which can quickly act on the skin surface, instantly adsorb excess oil, temporarily shrink dilated pores, and provide an instant matte appearance, which is the first line of defense for oil control, solving the problem of "current oiliness";

[0011] Since the secretion of oil is closely related to inflammatory response, the active ingredients in the extract of Stephania tetrandra (e.g. tetrandrine) can effectively inhibit the activity of key inflammatory factors such as phospholipase A2 and cyclooxygenase, thereby reducing the inflammatory state of the sebaceous gland unit from the source. By inhibiting such inflammatory stimulation, the overactive sebaceous glands can be effectively reduced, thereby reducing the synthesis and secretion of oil from the intermediate link. This is the second line of defense for oil control, targeting one of the driving factors of oil secretion.

[0012] In addition to its soothing neurogenic inflammation effect: by stabilizing mast cells, reducing the stress response caused by external stimuli (such as stress, friction) such as neuropeptides (e.g. substance P), thereby reducing "stress-induced oil secretion"; it can also consolidate the skin barrier: by enhancing the skin barrier function, reducing the excessive trans-epidermal water loss caused by barrier damage, thereby avoiding "compensatory oil secretion" to maintain moisture, and its excellent soothing properties can buffer the dryness or irritation that may be caused by Hamamelis virginiana, thereby improving the mildness of the formulation;

[0013] The above three components do not act in isolation, but form a precise closed loop: Hamamelis virginiana addresses immediate oil removal, but may cause dryness; the extract of Stephania tetrandra reduces oil production from the root of inflammation; and dipotassium glycyrrhizinate ensures that the entire oil control process takes place in a healthy skin barrier and stable neural response environment, preventing side effects, thereby significantly improving the durability and safety of oil control. This synergy makes the composition particularly suitable for oily skin with inflammation and sensitivity.

[0014] Another object of the present application is to provide a cosmetic containing the above-mentioned multi-target synergistic oil control composition, wherein the mass percentage of Hamamelis virginiana extract is 0.1% to 5%, the mass percentage of Stephania tetrandra extract is 0.01% to 3%, and the mass percentage of dipotassium glycyrrhizinate is 0.05% to 2%.

[0015] With the above further arrangement, the cosmetic contains the above-mentioned multi-target synergistic oil control composition, wherein the lower limit of 0.1% for Hamamelis virginiana extract is the minimum effective concentration that ensures that tannic acid in it can produce immediate astringency and oil absorption effect. Below this concentration, the astringency is not obvious and the oil control effect is weak. The upper limit of 5% is mainly based on safety considerations. When the concentration is too high, high content of tannic acid may cause excessive astringency, dryness and even irritation to the skin, which in turn damages the barrier health, which is contrary to the purpose of "mild oil control" of the present application. The preferred range is 1% to 3%;

[0016] The lower limit of 0.01% for Stephania tetrandra extract is the effective concentration at which its active ingredients (such as tetrandrine) can effectively inhibit inflammatory targets such as phospholipase A2 at the cellular level, thereby intervening in the secretion of "inflammatory sebum". The upper limit of 3% is mainly limited by the cost of raw materials, the solubility of the extract and the compatibility of color. Too high a concentration will significantly increase the product cost and may lead to the formulation being too dark or precipitation, affecting the appearance of the product. The preferred range is 0.1%-1%.

[0017] The lower limit of dipotassium glycyrrhizate (0.05%) is the recognized effective concentration at which it exerts a clear soothing, anti-inflammatory, and barrier-stabilizing effect. The upper limit of 2% follows common recommended concentrations in cosmetic ingredient safety guidelines to ensure the absolute gentleness of the product. Although it has a high safety profile, excessive addition is unnecessary and may affect the skin feel of the formulation (e.g., slightly sticky). Its dosage needs to be coordinated with that of witch hazel extract. For example, when the witch hazel dosage is high (e.g., >3%), the dosage of dipotassium glycyrrhizate should also be appropriately increased (e.g., >0.5%) to fully exert its buffering and soothing effects on dryness.

[0018] Through the above-mentioned meticulous proportion design, it is ensured that the three active ingredients can maximize their synergistic oil-controlling effects of "immediate astringency - inflammation blocking - barrier stabilization" within their respective safe and effective concentration windows.

[0019] A further provision of the present invention includes cosmetically acceptable excipients, said excipients comprising one or more of solvents, humectants, skin conditioning agents, emulsifiers, thickeners, emollients, skin feel modifiers, pH adjusters, and preservatives; wherein the solvent is deionized water; the humectant is one or more of glycerin, butylene glycol, or dipropylene glycol; the thickener is xanthan gum or acrylate / C10-30 alkanol crosspolymer; the preservative is one or more of phenoxyethanol, ethylhexylglycerin, or chlorphenesin; the pH adjuster is citric acid, lactic acid, or triethanolamine; the skin conditioning agent is panthenol; the emulsifier is one or more of PEG-100 stearate, cetearyl oleate sorbitan ester, or polyglycerol-3-methylglucose distearate; the emollient is isononyl isononanoate; the skin feel modifier is polydimethylsiloxane; and the cosmetic is a toner, serum, lotion, cream, oil-control mask, or oil-absorbing powder.

[0020] The present invention is further configured such that: the cosmetic is an essence, and by mass percentage of the cosmetic, the moisturizer is 3%-12%, the thickener is 0.05%-0.3%, the skin conditioning agent is 0.5%-5%, the preservative is 0.1-1.2%, and the balance is a pH adjuster and a solvent, wherein the pH adjuster is used to adjust the pH value of the cosmetic to 5.0-6.0.

[0021] The present invention is further configured such that: the cosmetic is a face cream, and by mass percentage of the cosmetic, the moisturizer is 5%-15%, the thickener is 0.05%-0.5%, the preservative is 0.5%-1.0%, the emollient is 3%-12%, the emulsifier is 1%-6%, the skin feel modifier is 0.5%-5%, and the balance is a pH adjuster and a solvent, wherein the pH adjuster is used to adjust the pH value of the cosmetic to 5.0-6.0.

[0022] Using the above technical solution, the reasonable configuration of excipients provides a stable, comfortable and safe carrier for the entire composition. The solvent serves as the matrix and is added up to 100%. The moisturizer provides basic moisturization. If the amount is less than 3%, the basic moisturization will be insufficient and it will be unable to balance the dryness that the oil-controlling ingredients may bring, increasing the risk of barrier damage. If it is more than 8%, the product may become too sticky, which goes against the refreshing skin feel that oily skin seeks.

[0023] Thickeners are used to adjust product viscosity and improve skin feel. If the amount is less than 0.05%, the product will be too thin, like water, which will affect the user experience and the retention of active ingredients on the skin. If the amount is more than 0.3%, it will easily produce a sticky feeling or risk pilling, and is especially unsuitable for subsequent layering of sunscreen or foundation.

[0024] When preparing lotions or creams, emulsifiers are added to stabilize the oil and water phases. The formula needs to be adjusted to a pH of 5.0-6.0 using a pH adjuster. This slightly acidic range is the optimal range for maintaining the stability of dipotassium glycyrrhizate and plant extracts, while gently conditioning the stratum corneum and avoiding potential disturbance to the skin barrier caused by high pH values. In addition, preservatives (such as phenoxyethanol) must be added to ensure the product's microbial safety within its shelf life. The types and amounts of these excipients are the foundation for ensuring product stability, safety, and a good user experience. Too little may lead to product instability or a poor skin feel, while too much may introduce unnecessary irritation. Based on the composition's focus on immediate astringency and deep regulation, the cosmetic is preferably a toner or serum. The toner formulation is beneficial for quickly tightening pores and absorbing oil in the first step of skincare; while the serum formulation can carry a higher concentration of active ingredients to achieve deeper anti-inflammatory and barrier-stabilizing effects. In addition, this composition can also be applied to local oil-control serums or makeup primers to specifically treat oily areas such as the T-zone. Detailed Implementation

[0025] This invention provides a multi-target synergistic oil-control composition, the composition comprising North American witch hazel extract, Stephania tetrandra extract, and dipotassium glycyrrhizate.

[0026] This invention also provides a cosmetic product using a multi-target synergistic oil-control composition. The cosmetic product contains the aforementioned multi-target synergistic oil-control composition, preferably as a toner, serum, lotion, cream, oil-control mask, or oil-absorbing powder. By weight percentage, the North American witch hazel extract is 0.1%-5%, the Stephania tetrandra extract is 0.01%-3%, and the dipotassium glycyrrhizate is 0.05%-2%. It should be noted that any significant deviation of the ingredient proportions from the above ranges may disrupt the synergistic effect. For example, excessive witch hazel can cause irritation, while insufficient amounts may result in ineffective immediate effects; insufficient Stephania tetrandra may lead to weak anti-inflammatory and lipid-suppressing effects; and insufficient dipotassium glycyrrhizate may prevent effective buffering and stabilization.

[0027] In addition, cosmetics also contain cosmetically acceptable excipients, including one or more of solvents, moisturizers, skin conditioning agents, emulsifiers, thickeners, emollients, skin feel modifiers, pH adjusters, and preservatives.

[0028] Example 1: Refreshing Oil-Control Essence

[0029] This embodiment provides a serum with a light texture, high concentration of active ingredients, and a focus on efficient penetration and comprehensive anti-aging repair. The optimal formula composition ratio is shown in the table below:

[0030]

[0031]

[0032] Preparation process:

[0033] S1 Preparation of Aqueous Phase: Add deionized water to the main pot, turn on stirring and heating (to 75-80℃), slowly and evenly sprinkle in xanthan gum, stir until completely dissolved to form a homogeneous and transparent solution, add butylene glycol, glycerol, and panthenol, and keep warm and stir for 15 minutes.

[0034] S2 Cooling: Stop heating, start low-speed homogenization, and stir to cool to 40-45℃.

[0035] S3 Add Active Ingredients: Slowly add all active ingredients from Phase B (Witch Hazel Extract, Stephania Tetrandra Extract, Dipotassium Glycyrrhizate) to ensure that each ingredient is completely and evenly dispersed.

[0036] S4 Adjustment and Shaping: Add the C-phase preservative and stir until homogeneous. Finely adjust the pH of the product to a weakly acidic range of 5.0-5.5 using citric acid solution.

[0037] S5 discharge: Continue to stir slowly and cool to room temperature (25-30℃). After sampling and inspection, discharge and fill.

[0038] Example 2: Hydrating and Oil-Controlling Moisturizing Cream

[0039] This embodiment provides a refreshing face cream that combines oil control and basic moisturizing effects, suitable for oily skin when moisturizing is needed. The formula composition ratio is the preferred data, as shown in the table below:

[0040]

[0041]

[0042] Preparation process:

[0043] S1 Heating the oil and aqueous phases: Add all components of phase A to the oil phase pot, heat to 75-80℃, and stir until completely melted and clear. Add all components of phase B (except triethanolamine) to the aqueous phase pot, heat to 75-80℃, and continue stirring until the polymer is completely dissolved and dispersed, and the system is homogeneous.

[0044] S2 Emulsification: Slowly add the oil phase (phase A) to the aqueous phase (phase B) while homogenizing at high speed (approximately 2500-3000 rpm) for 3-5 minutes to form a uniform and fine emulsion.

[0045] S3 Neutralization and Insulation: Dilute the required amount of triethanolamine (D phase) with a small amount of deionized water and slowly add it to the emulsion under homogeneous conditions. The paste will thicken instantly. Maintain the temperature at 75-80℃ and stir continuously at low speed for 15 minutes to complete the emulsification process.

[0046] S4 Cooling and Addition of Active Ingredients: Stop heating, turn on low-speed homogenizing stirring to cool, and when the temperature drops below 40°C, slowly add all active ingredients in phase C to ensure uniform mixing.

[0047] S5 discharge: Continue stirring and cooling to 30-35℃, add the remaining preservative, stir evenly, and after passing the inspection, discharge and fill.

[0048] Examples and efficacy evaluation

[0049] To verify the multi-target synergistic efficacy of the oil-control composition of the present invention (represented by the serum in Example 1), we conducted systematic in vitro experiments and human clinical evaluations. The test methods, results and conclusions are described in detail below with reference to the formulation of Example 1 (serum).

[0050] (1) In vitro test evaluation

[0051] Test item 1: Inhibitory effect on lipid synthesis in sebaceous gland cells

[0052] Experimental Methods: A human sebaceous gland cell (SEB-1) in vitro culture model was used. The serum was added, and a specific inducer was used to stimulate lipid synthesis in the cells. After 48 hours of culture, the intracellular lipid content was quantified using Nile Red staining. All percentages are based on the mass percentage of the cosmetic product. The following experimental and control groups were set up:

[0053] Blank control group: No North American witch hazel extract, Stephania tetrandra extract, or dipotassium glycyrrhizate were added;

[0054] 2.0% North American witch hazel extract group: This is a single-component control group containing 2.0% North American witch hazel extract, but not containing Stephania tetrandra extract or dipotassium glycyrrhizate;

[0055] 0.5% Stephania tetrandra extract group: This is a single-component control group containing 0.5% Stephania tetrandra extract, but not containing witch hazel extract or dipotassium glycyrrhizate.

[0056] 0.8% dipotassium glycyrrhizate group: This is a single-component control group containing 0.8% dipotassium glycyrrhizate, but not containing witch hazel extract or Stephania tetrandra extract;

[0057] Full Formula Group 1: Contains all three ingredients, including 2.0% by weight of North American witch hazel extract, 0.5% by weight of Stephania tetrandra extract, and 0.8% by weight of dipotassium glycyrrhizate.

[0058] Full Formula Group 2: Contains all three ingredients, including 0.1% North American witch hazel extract, 0.01% Stephania tetrandra extract, and 0.05% dipotassium glycyrrhizate.

[0059] Full Formula Group 3: Contains all three ingredients, with North American witch hazel extract at 5% by weight, Stephania tetrandra extract at 3% by weight, and dipotassium glycyrrhizate at 2% by weight.

[0060] The data and results are shown in the table below:

[0061]

[0062]

[0063] Conclusion: The data fully demonstrate that the three active ingredients, when in the recommended ratio, produced a strong synergistic lipid-inhibiting effect. Their effects are not simply additive. The full formula group 1 achieved excellent efficacy (45% inhibition rate) while avoiding the irritation risks that may be caused by excessively high concentrations, demonstrating the high efficiency and safety of this oil-controlling composition.

[0064] Test item 2: Inhibition rate of IL-6 expression (a cytokine)

[0065] Experimental Methods: In a SEB-1 cell inflammation model, the inhibitory effect of the composition on the key inflammatory factor IL-6 was detected. The following experimental groups and control groups were set up:

[0066] Model control group: The added essence did not contain any of the following ingredients: North American witch hazel extract, Stephania tetrandra extract, or dipotassium glycyrrhizate.

[0067] 2.0% North American witch hazel extract group: The added serum contains 2.0% North American witch hazel extract and does not contain the other two ingredients;

[0068] 0.5% Stephania tetrandra extract group: The added essence contains 0.5% Stephania tetrandra extract, but does not contain the other two ingredients;

[0069] 0.8% Dipotassium Glycyrrhizate Group: The added serum contains 0.8% dipotassium glycyrrhizate and does not contain the other two ingredients;

[0070] Dual-component formula: The added serum contains 2.0% North American witch hazel extract and 0.8% dipotassium glycyrrhizate, but does not contain Stephania tetrandra extract;

[0071] Full Formula Group 1: Contains all three ingredients, including 2.0% by weight of North American witch hazel extract, 0.5% by weight of Stephania tetrandra extract, and 0.8% by weight of dipotassium glycyrrhizate.

[0072] Full Formula Group 2: Contains all three ingredients, including 0.1% North American witch hazel extract, 0.01% Stephania tetrandra extract, and 0.05% dipotassium glycyrrhizate.

[0073] Full Formula Group 3: Contains all three ingredients, with North American witch hazel extract at 5% by weight, Stephania tetrandra extract at 3% by weight, and dipotassium glycyrrhizate at 2% by weight.

[0074] The experimental data are shown in the table below:

[0075]

[0076]

[0077] Experimental conclusion: The results of this experiment show that the oil-controlling composition of the present invention can not only directly inhibit lipid synthesis, but also effectively block key inflammatory pathways related to oily and acne-prone skin (IL-6 expression downregulated by 68%) through powerful multi-component synergistic effects. This dual mechanism of "lipid inhibition" and "anti-inflammation" provides solid in vitro experimental evidence for the product to achieve the effects of oil control, soothing and preventing acne from the root.

[0078] (2) Human clinical evaluation

[0079] Test Project: We recruited 35 volunteers aged 25-40 with mild to moderate oily skin (some with sensitivity) to use the serum of Example 1 for 4 weeks in a self-controlled clinical study.

[0080] Test instruments and methods:

[0081] Sebum secretion: using The SM 810 probe measures sebum content in four areas: forehead, cheeks, chin, and nose, at the same time points before use (D0), 2 weeks after use (D14), and 4 weeks after use (D28).

[0082] Pore ​​size: using -CR Facial Image Analysis System quantitatively analyzes the number and average area of ​​pores on both sides of the nose.

[0083] Skin erythema index: using The MX18 probe measures the erythema index (a value) of the reddened area of ​​the cheek to assess the soothing effect.

[0084] Subject self-assessment: Subjects' subjective evaluations of oil control, pore minimization, and soothing effects were collected through questionnaires.

[0085] Data and Results (mean, n=35):

[0086] The objective data measured by the instrument are shown in the table below:

[0087]

[0088] Subject self-assessment results (at day 28)

[0089] 94.3% (33 / 35) of the participants felt that their facial oil production was significantly reduced and that the matte finish lasted longer.

[0090] 88.6% (31 / 35) of the participants felt that their pores looked finer and cleaner.

[0091] 91.4% (32 / 35) of the participants reported that their skin redness and sensitivity improved, and that the product was gentle and non-irritating.

[0092] 85.7% (30 / 35) of the participants expressed satisfaction or high satisfaction with the overall oil control and soothing effects of the product.

[0093] in conclusion:

[0094] The results of a 4-week human clinical trial indicate that the composition of this invention can:

[0095] Significantly reduces sebum secretion: sebum content decreases by 37.5%, demonstrating excellent oil control;

[0096] Effectively minimizes pores: The visual area of ​​pores is reduced by 21.6%, resulting in smoother skin texture;

[0097] Significantly soothes redness: The erythema index decreased by 17.3%, confirming its good anti-inflammatory and soothing effects, especially suitable for oily and sensitive skin;

[0098] Excellent subjective evaluation: More than 90% of the subjects recognized its oil control, pore shrinking and soothing effects, and it was well tolerated.

[0099] In summary, this invention provides a synergistic oil-control composition based on North American witch hazel extract, Stephania tetrandra extract, and dipotassium glycyrrhizate. The core innovation of this composition lies in overcoming the limitations of traditional oil-control technologies that rely on a single action. By constructing a multi-target closed-loop regulatory mechanism of "immediate astringency - inflammation blocking - barrier stabilization," it achieves systematic management of skin sebum secretion.

[0100] Specifically, in vitro experiments have demonstrated that the composition inhibits lipid synthesis in sebaceous gland cells by up to 45% and significantly inhibits the expression of the inflammatory factor IL-6 (inhibition rate 68%). Its effect is significantly better than that of each component used alone, fully demonstrating the synergistic effect among the three. Human clinical evaluation further shows that after continuous use for 4 weeks, the composition can reduce facial sebum secretion by 37.5%, shrink the visual area of ​​pores by 21.6%, and reduce the erythema index by 17.3%. The objective data are highly consistent with the subjective evaluation of the subjects, verifying its comprehensive efficacy of rapid oil control, long-lasting stabilization, and soothing repair.

[0101] Compared with existing technologies, the composition of this invention not only significantly improves oil control efficiency, but also effectively avoids the risks of skin dryness, barrier damage and compensatory oil rebound caused by traditional strong oil control ingredients through the synergistic effect of anti-inflammation and barrier repair. It is especially suitable for long-term care of oily and sensitive skin.

[0102] Therefore, this invention not only provides a highly efficient, gentle, and clearly defined oil-controlling active composition, but also offers a novel "multi-target synergistic" formulation design approach for the cosmetics industry. This composition is easy to industrially produce and can be widely applied to various dosage forms such as serums, creams, and toners, demonstrating promising market prospects and application value.

Claims

1. A multi-target synergistic oil-control composition, characterized in that, The composition comprises North American witch hazel extract, Stephania tetrandra extract, and dipotassium glycyrrhizate.

2. A cosmetic product, characterized in that, It contains the multi-target synergistic oil-control composition as described in claim 1.

3. The cosmetic product according to claim 2, characterized in that, The percentage of North American witch hazel extract by mass percentage is 0.1%-5%, the percentage of Stephania tetrandra extract by mass percentage is 0.01%-3%, and the percentage of dipotassium glycyrrhizate by mass percentage is 0.05%-2%.

4. The cosmetic product according to claim 3, characterized in that, It also contains cosmetically acceptable excipients, including one or more of solvents, humectants, skin conditioning agents, emulsifiers, thickeners, emollients, skin feel modifiers, pH adjusters, and preservatives.

5. The cosmetic product according to any one of claims 2-4, characterized in that, The cosmetics mentioned are toners, serums, lotions, creams, oil-control masks, or oil-absorbing powders.

6. The cosmetic product according to claim 5, characterized in that, The cosmetic is an essence, and by mass percentage, the moisturizer is 3%-12%, the thickener is 0.05%-0.3%, the skin conditioning agent is 0.5%-5%, the preservative is 0.1-1.2%, and the balance is a pH adjuster and a solvent. The pH adjuster is used to adjust the pH value of the cosmetic to 5.0-6.

0.

7. The cosmetic product according to claim 5, characterized in that, The cosmetic product is a face cream. By weight percentage, the moisturizer is 5%-15%, the thickener is 0.05%-0.5%, the preservative is 0.5%-1.0%, the emollient is 3%-12%, the emulsifier is 1%-6%, the skin feel modifier is 0.5%-5%, and the balance is a pH adjuster and a solvent. The pH adjuster is used to adjust the pH value of the cosmetic product to 5.0-6.

0.

8. The cosmetic product according to claim 6 or 7, characterized in that, The solvent is deionized water; the humectant is one or more of glycerin, butylene glycol, or dipropylene glycol; the thickener is xanthan gum or acrylate / C10-30 alkanol cross-linked polymer; the preservative is one or more of phenoxyethanol, ethylhexylglycerin, or chlorphenesin; and the pH adjuster is citric acid, lactic acid, or triethanolamine.

9. The cosmetic product according to claim 8, characterized in that, The skin conditioning agent is panthenol; the emulsifier is one or more of PEG-100 stearate, cetearyl oleate sorbitol ester, and polyglycerol-3-methylglucose distearate; the emollient is isononyl isononanoate; and the skin feel modifier is polydimethylsiloxane.

Images